These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6706214)

  • 1. Search for evidence of a viral aetiology for inflammatory bowel disease.
    Yoshimura HH; Estes MK; Graham DY
    Gut; 1984 Apr; 25(4):347-55. PubMed ID: 6706214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulcerative colitis and Crohn's disease tissue cytotoxins.
    McLaren LC; Gitnick G
    Gastroenterology; 1982 Jun; 82(6):1381-8. PubMed ID: 7067958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytopathic effects in cultures inoculated with material from Crohn's disease.
    Moráin CO; Prestage H; Harrison P; Levi AJ; Tyrrell DA
    Gut; 1981 Oct; 22(10):823-6. PubMed ID: 7297913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cultivation of viral agents from Crohn's disease. A new sensitive system.
    Gitnick GL; Arthur MH; Shibata I
    Lancet; 1976 Jul; 2(7979):215-7. PubMed ID: 59237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus isolation studies in Crohn's disease: a negative report.
    Phillpotts RJ; Hermon-Taylor J; Brooke BN
    Gut; 1979 Dec; 20(12):1057-62. PubMed ID: 527878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the isolation of a new virus from ulcerative colitis patients. Comparison with virus derived from Crohn's disease.
    Gitnick GL; Rosen VJ; Arthur MH; Hertweck SA
    Dig Dis Sci; 1979 Aug; 24(8):609-19. PubMed ID: 467212
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunity to cytopathic agents associated with Crohn's disease: a negative study.
    Chiba M; McLaren LC; Strickland RG
    Gut; 1982 Apr; 23(4):333-9. PubMed ID: 7042483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electron microscopic studies of viral agents in Crohn's disease.
    Gitnick GL; Rosen VJ
    Lancet; 1976 Jul; 2(7979):217-9. PubMed ID: 59238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR; Depew WT
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease.
    Giaffer MH; Holdsworth CD; Duerden BI
    Gut; 1992 May; 33(5):646-50. PubMed ID: 1612481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-wall deficient bacteria in inflammatory bowel disease.
    Ibbotson JP; Pease PE; Allan RN
    Eur J Clin Microbiol; 1987 Aug; 6(4):429-31. PubMed ID: 3665900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral investigations in ulcerative colitis and regional enteritis.
    Farmer GW; Vincent MM; Fuccillo DA; Horta-Barbosa L; Ritman S; Sever JL; Gitnick GL
    Gastroenterology; 1973 Jul; 65(1):8-18. PubMed ID: 4352745
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell wall-defective variants of pseudomonas-like (group Va) bacteria in Crohn's disease.
    Parent K; Mitchell P
    Gastroenterology; 1978 Sep; 75(3):368-72. PubMed ID: 680490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease.
    Naser SA; Ghobrial G; Romero C; Valentine JF
    Lancet; 2004 Sep 18-24; 364(9439):1039-44. PubMed ID: 15380962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications.
    Adar T; Shteingart S; Ben-Ya'acov A; Shitrit AB; Livovsky DM; Shmorak S; Mahamid M; Melamud B; Vernea F; Goldin E
    Dig Dis Sci; 2016 Jul; 61(7):1915-24. PubMed ID: 26874691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase A2 activating protein and idiopathic inflammatory bowel disease.
    Peterson JW; Dickey WD; Saini SS; Gourley W; Klimpel GR; Chopra AK
    Gut; 1996 Nov; 39(5):698-704. PubMed ID: 9014769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues.
    Walmsley RS; Anthony A; Sim R; Pounder RE; Wakefield AJ
    J Clin Pathol; 1998 Sep; 51(9):657-61. PubMed ID: 9930068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.